Hypertension after renal transplantation

Area of Science:

• Nephrology
• Transplantation
• Cardiovascular Medicine

Background:

• Hypertension is prevalent in nearly 90% of renal graft recipients under current immunosuppression protocols.
• Factors contributing to elevated blood pressure include impaired renal function, calcineurin inhibitors, renin secretion, arterial stenosis, polycythemia, and donor hypertension.
• Even mild blood pressure elevation negatively affects recipient and graft survival by exacerbating vascular injury.

Purpose of the Study:

• To review the causes and implications of elevated blood pressure in renal allograft recipients.
• To discuss the impact of blood pressure on graft and patient survival.
• To outline current antihypertensive treatment strategies for renal transplant patients.

Main Methods:

• Literature review of studies on hypertension in renal transplant recipients.
• Analysis of factors contributing to elevated blood pressure post-transplantation.
• Evaluation of the prognostic significance of blood pressure parameters.

Main Results:

• Key causes identified include chronic allograft nephropathy, immunosuppressants, renin-angiotensin system activation, arterial stenosis, and donor predisposition.
• Elevated systolic blood pressure and abnormal circadian patterns are particularly detrimental.
• Both recipient and graft survival are significantly impacted by blood pressure elevation.

Conclusions:

• Management of hypertension is critical for improving outcomes in renal transplant recipients.
• While ACE inhibitors are indicated, diuretics and calcium channel blockers remain primary treatments due to sodium retention's role in vasoconstriction.
• Addressing blood pressure is essential for long-term graft and patient well-being.